Pub. L. 116-260, div. CC, tit. I, subtit. B, sec. 112 (as amended)

PROVIDING THE MEDICARE PAYMENT ADVISORY COMMISSION AND MEDICAID AND CHIP PAYMENT AND ACCESS COMMISSION WITH ACCESS TO CERTAIN DRUG PAYMENT INFORMATION, INCLUDING CERTAIN REBATE INFORMATION.

Year: 2026Length: 602 wordsOfficial source
SEC. 112. PROVIDING THE MEDICARE PAYMENT ADVISORY COMMISSION AND MEDICAID AND CHIP PAYMENT AND ACCESS COMMISSION WITH ACCESS TO CERTAIN DRUG PAYMENT INFORMATION, INCLUDING CERTAIN REBATE INFORMATION. (a) Access to Certain Part D Payment Data.—Section 1860D-15(f) of the Social Security Act (42 U.S.C. 1395w-115(f)) is amended— (1) in paragraph (2)— (A) in subparagraph (A)(ii), by striking “and” at the end; (B) in subparagraph (B), by striking the period at the end and inserting “; and”; and (C) by inserting at the end the following new subparagraph: “(C) by the Executive Director of the Medicare Payment Advisory Commission for purposes of monitoring, making recommendations for, and analysis of the program under this title and by the Executive Director of the Medicaid and CHIP Payment and Access Commission for purposes of monitoring, making recommendations for, and analysis of the Medicaid program established under title XIX and the Children’s Health Insurance Program under title XXI.” ; and (2) by adding at the end the following new paragraph: “(3) Additional restrictions on disclosure of information.— “(A) In general.—The Executive Directors described in paragraph (2)(C) shall not disclose any of the following information disclosed to such Executive Directors or obtained by such Executive Directors pursuant to such paragraph, with respect to a prescription drug plan offered by a PDP sponsor or an MA-PD plan offered by an MA organization: “(i) The specific amounts or the identity of the source of any rebates, discounts, price concessions, or other forms of direct or indirect remuneration under such prescription drug plan or such MA-PD plan. “(ii) Information submitted with the bid submitted under section 1860D-11(b) by such PDP sponsor or under section 1854(a) by such MA organization. “(iii) In the case of such information from prescription drug event records, information in a form that would not be permitted under section 423.505(m) of title 42, Code of Federal Regulations, or any successor regulation, if released by the Centers for Medicare & Medicaid Services. “(B) Clarification.—The restrictions on disclosures described in subparagraph (A) shall also apply to disclosures to individual Commissioners of the Medicare Payment Advisory Commission or of the Medicaid and CHIP Payment and Access Commission.” . (b) Access to Certain Rebate and Payment Data Under Medicare and Medicaid.—Section 1927(b)(3)(D) of the Social Security Act (42 U.S.C. 1396r-8(b)(3)(D)) is amended— (1) in the matter before clause (i), by striking “subsection (a)(6)(A)(ii)” and inserting “subsection (a)(6)(A)”; (2) in clause (v), by striking “and” at the end; (3) in clause (vi), by striking the period at the end and inserting “, and”; (4) by inserting after clause (vi) the following new clause: “(vii) to permit the Executive Director of the Medicare Payment Advisory Commission and the Executive Director of the Medicaid and CHIP Payment and Access Commission to review the information provided.” ; (5) in the matter at the end, by striking “1860D-4(c)(2)(E)” and inserting “1860D-4(c)(2)(G)”; and (6) by adding at the end the following new sentences: “Any information disclosed to the Executive Director of the Medicare Payment Advisory Commission or the Executive Director of the Medicaid and CHIP Payment and Access Commission pursuant to this subparagraph shall not be disclosed by either such Executive Director in a form which discloses the identity of a specific manufacturer or wholesaler or prices charged for drugs by such manufacturer or wholesaler. Such information also shall not be disclosed by either such Executive Director to individual Commissioners of the Medicare Payment Advisory Commission or of the Medicaid and CHIP Payment and Access Commission in a form which discloses the identity of a specific manufacturer or wholesaler or prices charged for drugs by such manufacturer or wholesaler.”.
Pub. L. 116-260, div. CC, tit. I, subtit. B, sec. 112 (as amended): PROVIDING THE MEDICARE PAYMENT ADVISORY COMMISSION AND MEDICAID AND CHIP PAYMENT AND ACCESS COMMISSION WITH ACCESS TO CERTAIN DRUG PAYMENT INFORMATION, INCLUDING CERTAIN REBATE INFORMATION. | Justis AI